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Summary background In many countries including South Africa, the increasing human immunodeﬁciency virus
(HIV) and tuberculosis (TB) epidemics have impacted signiﬁcantly on already weakened public health
services. This paper reviews the scope, process and performance of the HIV and TB services in a primary
care setting where antiretroviral therapy is provided, in Khayelitsha, South Africa, in order to assess
whether there is a need for some form of integration.
methods The scope and process of both services were assessed through observations of the service and
individual and group interviews with key persons. The performance was assessed by examining the
2001–2002 reports from the health information system and clinical data.
results The TB service is programme oriented to the attainment of an 85% cure rate amongst smear-
positive patients while the HIV service has a more holistic approach to the patient with HIV. The TB
service is part of a well-established programme that is highly standardized. The HIV service is in the pilot
phase. There is a heavy load at both services and there is large degree of cross-referral between the two
services. There are lessons that can be learnt from each service. There is an overlap of activities,
duplication of services and under-utilization of staff. There are missed opportunities for TB and HIV
prevention, diagnosis and management.
conclusions The study suggests that there may be beneﬁts to integrating HIV and TB services.
Constraints to this process are discussed.
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Introduction
In many parts of sub-Saharan Africa, tuberculosis (TB) has
been endemic for many decades and transmission has been
enhanced by overcrowding and poor living conditions.
The advent of the human immunodeﬁciency virus (HIV)
epidemic has increased the burden of TB signiﬁcantly, as
untreated HIV infection leads to progressive immune
deﬁciency and increased susceptibility to infections such as
TB. In southern Africa, TB is the leading cause of mortality
in HIV-infected persons and HIV is driving the TB
epidemic.
Human immunodeﬁciency virus is the strongest factor
capable of promoting progression of Mycobacterium
tuberculosis (MTB) infection to active tuberculosis (Rieder
et al. 1989) both in people with recently acquired and
latent MTB infections (Maher et al. 2002). The life-time
risk for active TB in an HIV-negative person is 5–10%,
while the annual risk in HIV-infected persons is 5–15%
(Von Reyn 1999).
Research shows that even in areas where there is a good TB
controlprogramme,whenthesero-prevalenceofHIVis>20%,
the annual percentage increase in TB will be high at over 10%
(Cantwell and Binkin 1996). However, TB accelerates HIV
disease progression and is associated with decreased survival.
TB speciﬁc mortality is fourfold higher among HIV-infected
patients than amongst the uninfected (17.8 and 4.4 deaths per
100 per year for HIV-infected and uninfected patients,
respectively) (Connolly et al. 1999). In addition, the TB
epidemic in persons infected with HIV increases the infectious
pool and the risk of TB transmission in the community,
whether or not HIV-infected (Maher et al. 2002).
Clinical interventions have demonstrated that the burden
of TB can be reduced in persons infected with HIV
(Anderson & Maher 2001). The World Health Organiza-
tion (WHO) has formulated guidelines for collaborating
TB and HIV services or activities (WHO 2003).
One such initiative, ProTest, was started in 1999 and
facilitates HIV/AIDS/STI/TB care. It uses Voluntary
Counselling and Testing (VCT) as an entry point to HIV
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TB prevention and management. It should strengthen HIV
management by providing cotrimoxazole prophylaxis and
treatment for opportunistic infections (Godfrey-Faussett
et al. 2002). Recently it was suggested, following on
lessons learnt with ProTest in Zambia, that ProTest services
could be extended to provide antiretroviral therapy (ART)
(Ayles and Ginwala 2003).
Mahendradhata (personal communication) has reviewed
interventions to promote collaboration between HIV and
TB services and they conclude that practical ways to deliver
these interventions are not clear nor the beneﬁts and
constraints involved.
In many countries, including South Africa, the increasing
HIV and TB epidemics have impacted signiﬁcantly on
already weakened public health services. As new models
for HIV care are being developed, and ART is provided,
every effort should be made to determine the optimal
model for TB and HIV care.
In 2000, a pilot project was launched in Khayelitsha,
South Africa to provide a comprehensive continuum of
care for HIV-infected persons, including ART. However it
was soon realised that a comprehensive TB/HIV service
may be more advantageous due to the large numbers of co-
infected patients. The purpose of this paper is to present
the initial ﬁndings from a review of the HIV and TB
services in this primary care setting where ART is provided,
in order to assess whether they should be integrated.
Material and methods
Study site
Khayelitsha is a poor township in the metropolitan area of
Cape Town with 500 000 inhabitants. Approximately 30%
of the population live in informal housing while over 45%
are unemployed. Most residents rely on public primary
healthcareservices.Theservicesarelimitedbyalackofstaff
and resources. Three primary care centres or Community
Health Centres (CHCs) provide curative care including HIV
care, and 10 other services provide TB, sexually transmitted
infections (STI) and Child Health care. Two of the TB
services areatthesamesiteastheCHC. Atboththecurative
and TB services, the patient load is usually high.
The annual sero-prevalence study at ante-natal services
conducted in 2001 showed that 25% of pregnant mothers
were HIV-infected. Khayelitsha had the highest annual TB
case detection rate in the Western Cape Province at 1031
per 100 000 population in 2001.
In January 1999, the Health Department of the Provin-
cial Administration of the Western Cape (PAWC) intro-
duced a programme for the Prevention of Mother To Child
Transmission at the two midwife-run Obstetric Units. HIV
prevalence amongst pregnant women increased from 15%
in 1999 to 21% in 2001 and 25% in 2002. In April 2000,
PAWC and Me ´decins Sans Frontie `res (MSF) opened
services for patients with HIV-related problems within the
three CHCs.
Methods
The scope and process of the TB and HIV services were
assessed through observations of the service and individual
and group interviews with key persons in both the HIV and
TB services, carried out in January 2003 by a clinician/
researcher.
The performance of the services was assessed by
examining the 2001–2002 reports from the health infor-
mation system related to TB and HIV and the clinical data
of the patients registered in both services from January
2000 to December 2002. At the TB service, rates of TB and
HIV co-infection and clinical outcomes are recorded while
the HIV services prospectively monitor outcomes including
adherence to therapy, survival and the incidence of
opportunistic infections such as TB.
Results
Scope of the services
In January 2003 in Khayelitsha TB is diagnosed and
managed strictly according to World Health Organization
and national TB guidelines. The services are well estab-
lished and organised and concentrate on the diagnosis of
pulmonary TB through direct sputum microscopy, Directly
Observed Therapy Short Course (DOTS) and the attain-
ment of a cure rate of 85% in sputum smear positive cases.
TB staff are not conﬁdent in identifying extra-pulmonary
TB and TB in patients with negative smears.
VCT is offered to patients with TB. Although most
patients who are identiﬁed as HIV-infected are referred to
the HIV service, many do not attend. Cotrimoxazole is
often not provided at TB services.
In Khayelitsha theHIV pilot projects provide counselling,
support, prophylaxis, treatment, screening and when
necessary referral for conditions related to HIV, for patients
in WHO stage III and IV (WHO Classiﬁcation). Patients
with bacteriological conﬁrmation of TB are referred to the
TB service. Where the diagnosis is not conﬁrmed by smear
the TB service is very reluctant to start TB treatment.
Cultures are only done for re-treatment patients.
Patients can access the HIV service directly, but most are
referred from other services where VCT services operate.
Patients in stage I and II should be seen at the general
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The features of each of the services are presented in Table 1.
Process of the services
The TB service concentrates on its programmatic target of
achieving high cure rates in pulmonary smear positive
patients through the DOTS approach. Procedures are
highly standardised. Qualiﬁed nurses tend to conduct much
of the administrative work such as completion of the
register, checking for defaulters, pill checking and counting.
The HIV services have a more patient-centred approach
with TB seen as part of the realm of opportunistic
infections. Procedures are standardised. However an
attempt is made to identify extra-pulmonary TB and TB in
persons with negative sputum smears. HIV caregivers
attempt to support patients and an individual and group
support system is in place. Antiretroviral drugs are given
on a monthly basis. Qualiﬁed nurses mostly do clinical
work and counsellors promote adherence and do admin-
istrative work.
Performance of the services
The overall TB detection rate in Khayelitsha is
1031/100 000 in 2001. At any one moment a minimum of
2000 patients are on TB therapy. 23% of patients with TB
have extra-pulmonary TB.
The TB service shows a cure rate of 67% for new smear
positive patients in 2001, although 76% of patients
completed treatment. The cure rate for re-treatment cases
for the same period is 53% and 72% completed treatment.
The increasing burden of TB is limiting the ability of
services to perform daily directly observed treatment (both
in the community and at the clinic) and a small proportion
of patients are not supervised and are given treatment for
one or two weeks at a time.
The HIV status of 26% of TB patients is known and
of these 43% are HIV-infected. The uptake of VCT is
better at two and six months on treatment than at
diagnosis.
During the period under observation over 4000 HIV-
infected patients received care at the HIV services. At
the HIV services 13% of all patients were referred from
the Khayelitsha TB services during the period under
observation.
By the end of 2002 there were 350 patients on ART and
23% of these patients were referred from TB services. TB
patients have lower CD4 counts and are in more urgent
need of antiretroviral therapy.
TB is the commonest opportunistic infection at the
HIV service with pulmonary TB accounting for 21% and
Table 1 Comparison of features of TB and HIV services in primary care setting, prior to 2003 in Khayelitsha
TB service HIV service
Scope Emphasis on ﬁnding and curing
sputum smear positive pulmonary
TB.
No emphasis on identifying extra-
pulmonary TB or smear negative
TB.
VCT is offered (VCT) and, if
positive, referred to HIV clinic.
Cotrimoxazole prophylaxis rarely
provided.
Holistic approach to patient with HIV
– TB part of realm of opportunistic
infections seen.
Attempt to identify extra-pulmonary
and smear negative TB.
More comprehensive care:
Cotrimoxazole prophylaxis,
treatment of opportunistic infections
and antiretroviral therapy given for
those in need.
Process Programmatic towards TB only.
Well established national
programme (DOTS).
Highly standardised.
Supervise treatment.
Qualiﬁed staff tend to do
administrative and support work.
Patient-centred and attempt to
identify all opportunistic infections.
Lack of models, pilot project stage.
Standardised.
Support treatment.
Counsellors and volunteers do most
administrative and support work.
Performance >2000 patients on treatment.
VCT accepted by 26% of whom
43% are HIV-infected.
Cure rate 67%.
>4000 patients registered.
13% of patients referred from TB.
36% of patients with CD4 cell
counts below 200 cells/ll develop
TB disease in the following year.
93% undetectable HIV RNA at
6 months on ART.
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36% of patients with CD4 cell counts below 200 cells/ll
develop TB disease in the following year. Even though
there is a 66% reduction in TB incidence in patients on
antiretroviral therapy, 11% of these patients acquire TB
each year. Less than 5% of HIV-infected patients receive
Isoniazid prophylaxis for TB prevention.
93% and 84% of patients on ART have an undetectable
HIV RNA level after 6 and 12 months of therapy
respectively. The cumulative mortality at one year is 13%.
A review of a consecutive sample of 109 HIV-positive
patients with TB showed that 49% of them had negative
direct microscopy sputum smears but the culture of their
sputum was positive for MTB.
Discussion
The increasing burden of HIV and TB will place
constraints on the ability of public health services to
respond in Khayelitsha. The load at both services is high.
These results show that although there is a strong overlap
of activities and relationship between TB and HIV
services, there is duplication of services and under-
utilisation of staff.
Apart from the referral of patients between TB and HIV
services, they function independently of each other.
Separate patient folders are kept in each service, without
exchange between caregivers. The clinicians in the different
services are unaware of other treatments. Dually infected
patients are seen at two services and by different health
staff, at different times and places. There are missed
opportunities for Cotrimoxazole prophylaxis.
There are lessons that can be learnt from each service.
The pilot HIV service could learn from the more estab-
lished, organised and standardised TB service. Although
there are advantages to a very standardised and directed
approach to TB control, the rate of extra-pulmonary TB
and smear negative pulmonary TB is high and indicates the
need to expand the service to actively identify these
conditions in HIV infected persons. The current paradigm
of the TB programmes to focus on the detection and cure of
new smear positive pulmonary TB is challenged by HIV.
Yet many of the TB staff do not have the conﬁdence to
identify extra-pulmonary or smear negative TB. The
development of new guidelines together with training may
be necessary.
The performance levels, especially relating to TB are
inadequate. The high rate of adherence to ART, as
indicated by the high proportion with an undetectable HIV
RNA level, may suggest that there are lessons for the TB
services in supporting patients on chronic treatment and
promoting adherence.
The rate of VCT uptake at TB services is very low and
more emphasis should be placed on identifying HIV-
infected persons when patients attend the consultation
after 2 and 6 months of treatment.
This study suggests that there may be beneﬁts to
integrating HIV and TB services. However there may be a
number of constraints to this process. An often quoted
disadvantage of the integration of TB and HIV services is
the potential for the nosocomial spread of TB in areas
where patients with active TB (awaiting the conﬁrmation
of diagnosis) and highly susceptible HIV-infected patients
interact such as in waiting rooms. Although the high
prevalence of TB and studies on TB transmission in
endemic areas such as Khayelitsha suggest that exposure to
TB infection is ubiquitous, every attempt should be made
to separate patients coughing up sputum from HIV-
infected patients.
There may be resistance from policy makers who do not
recognise the beneﬁts. There may also be resistance from
staff who see any integration as extra work. This study
shows that because of duplication this should not be so. By
integrating TB and HIV care, the available human and
ﬁnancial resources can be optimally used. Efﬁciency gains
can also be anticipated by the use of a common informa-
tion system and a single set of records. A single venue and a
comprehensive consultation should result in less waiting
time for patients. In addition there is usually more donor
support for HIV programmes and this should beneﬁt the
TB programme.
For these reasons a pilot project has been initiated to
examine the feasibility of combining HIV and TB services
in Khayelitsha. This is being done in a stepped-wise
process, ﬁrst using each others records, then developing
standardised guidelines and training, followed by the
integration of clinical records and management.
Conclusion
Some form of integration of HIV and TB services is
required in order to respond to the urgent needs of these
two epidemics. An integrated HIV/TB service may have
many beneﬁts for the programmes, services and patients.
These beneﬁts and constraints will be monitored as the
pilot project proceeds.
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